OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling
Kine Andenæs, Ida G. Lunde, Naiyereh Mohammadzadeh, et al.
PLoS ONE (2018) Vol. 13, Iss. 7, pp. e0201422-e0201422
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Cardiac fibrosis
Nikolaos G. Frangogiannis
Cardiovascular Research (2020) Vol. 117, Iss. 6, pp. 1450-1488
Open Access | Times Cited: 717

The extracellular matrix as a multitasking player in disease
Achilleas D. Theocharis, Dimitra Manou, Nikos K. Karamanos
FEBS Journal (2019) Vol. 286, Iss. 15, pp. 2830-2869
Open Access | Times Cited: 389

Protein glycosylation in cardiovascular health and disease
John C. Chatham, Rakesh P. Patel
Nature Reviews Cardiology (2024) Vol. 21, Iss. 8, pp. 525-544
Closed Access | Times Cited: 16

Odd skipped-related 1 controls the pro-regenerative response of fibro-adipogenic progenitors
Georgios Kotsaris, Taimoor H. Qazi, Christian H. Bucher, et al.
npj Regenerative Medicine (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 17

Cross your heart? Collagen cross-links in cardiac health and disease
Lily S. Neff, Amy D. Bradshaw
Cellular Signalling (2020) Vol. 79, pp. 109889-109889
Open Access | Times Cited: 48

Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis
Vijayakrishna Kolur, Basavaraj Vastrad, Chanabasayya Vastrad, et al.
BMC Cardiovascular Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 38

Asporin, an extracellular matrix protein, is a beneficial regulator of cardiac remodeling
Chengqun Huang, Ankush Sharma, Reetu Thakur, et al.
Matrix Biology (2022) Vol. 110, pp. 40-59
Open Access | Times Cited: 26

Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases
Jinyang Zeng-Brouwers, Sony Pandey, Jonel Trebicka, et al.
Journal of Histochemistry & Cytochemistry (2020) Vol. 68, Iss. 12, pp. 887-906
Open Access | Times Cited: 37

Fibromodulin, a Multifunctional Matricellular Modulator
Zhong Zheng, H.S. Granado, Chaojing LI
Journal of Dental Research (2022) Vol. 102, Iss. 2, pp. 125-134
Open Access | Times Cited: 22

The role of fibromodulin in inflammatory responses and diseases associated with inflammation
Zhao Feng, Yang Bai, Xuerong Xiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Comprehensive bioinformatics analysis of hub genes in ischemic heart failure and atrial fibrillation
Meimei Zhou, Youkang Xu, Lili Zhang, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access

Nanoscale piezoelectric patches preserve electrical integrity of infarcted hearts
Luís Miguel Monteiro, Pedro Gouveia, Francisco Vasques‐Nóvoa, et al.
Materials Today Bio (2025), pp. 101742-101742
Open Access

Gene therapy of spinal cord injury using gene-modified Bone Marrow Stromal Cells with Fibromodulin expressing adenoviral vector in a rat SCI model
Mohammad Khosravi, Maryam Abbasalipour, Iraj Jafari Anarkooli, et al.
Research Square (Research Square) (2025)
Closed Access

Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload
Naiyereh Mohammadzadeh, Arne Olav Melleby, Sheryl Palmero, et al.
Cardiology (2020) Vol. 145, Iss. 3, pp. 187-198
Open Access | Times Cited: 30

Fibromodulin facilitates the osteogenic effect of Masquelet's induced membrane by inhibiting the TGF-β/SMAD signaling pathway
Kai Wang, Ming Zhou, Yuanshu Zhang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 7, pp. 1898-1913
Closed Access | Times Cited: 3

HAPLN1 knockdown inhibits heart failure development via activating the PKA signaling pathway
Tao Yan, Shushuai Song, Wendong Sun, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy
Huijuan Huang, Beibei Luo, Qingji Wang, et al.
Medical Science Monitor (2018) Vol. 24, pp. 7697-7709
Open Access | Times Cited: 32

Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments
Doa’a Al-u’datt, Carole C. Tranchant, Ahmed Al‐Dwairi, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115104-115104
Closed Access | Times Cited: 14

Characterizing Neonatal Heart Maturation, Regeneration, and Scar Resolution Using Spatial Transcriptomics
Adwiteeya Misra, Cameron Baker, Elizabeth M. Pritchett, et al.
Journal of Cardiovascular Development and Disease (2021) Vol. 9, Iss. 1, pp. 1-1
Open Access | Times Cited: 18

Emerging roles of proteoglycans in cardiac remodeling
Xiaoya Wang, Yi Lü, Yao Xie, et al.
International Journal of Cardiology (2018) Vol. 278, pp. 192-198
Closed Access | Times Cited: 21

Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus
Varun Alur, Varshita Raju, Basavaraj Vastrad, et al.
Bioscience Reports (2021) Vol. 41, Iss. 5
Open Access | Times Cited: 17

Dynamic and static biomechanical traits of cardiac fibrosis
Han Liu, Pengbei Fan, Fanli Jin, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top